Effect and safety of Substance P containing moisturizer in xerosis during retinoid treatment

Effect and safety of Substance P containing moisturizer in xerosis during retinoid treatment : Prospective controlled randomized split study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002412

Enrollment

Registered

2017-08-09

Start date

2017-07-04

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Product name: Lnk P11 (sh-Oligopeptide-73 Amide Acetate) The same subjects were allocate by random sampling method using Excel function to apply the local application agent (Lnk P11

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Those who taking isotretinoin, acitretin, alitretinoin. 2. Those who voluntarily signed the agreement and signed it after hearing enough explanation. 3. Those who can follow up during the test period

Exclusion criteria

Exclusion criteria: 1.If the application is difficult on the application site, hand, face etc. 2.Oral steroid-based medication is needed in the standard treatment. 3.If clobetasol is to be treated at the site of application. 4. Pregnant or lactating women and possibly pregnant women. 5.People who use functional cosmetics or medicines that can affect the test site within 3 months before the start of the study. 6.Those who have been treated on the test site within 6 months prior to the start of the study.

Design outcomes

Primary

Measure	Time frame
hydration of skin	—

Secondary

Measure	Time frame
transepidermal water loss	—

Countries

Korea, Republic of

Contacts

Public ContactHye-Jin Ahn

Kyung Hee University Hospital

anjamong@naver.com+82-2-958-8506

Outcome results